Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F J Bosques-Padilla

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Revista De Gastroenterologia De Mexico (English)|May 14, 2019
Response to Dr. Isaac Ruiz from Dr. Francisco Javier Bosques Padilla, on behalf of the consensus group of the Mexican Consensus on the Treatment of Hepatitis CF J Bosques-Padilla
Revista De Gastroenterologia De Mexico|July 1, 1991
[Medical treatment of biliary lithiasis. Orally administered biliary acids]F J Bosques Padilla, R F Barragán Villarreal
Revista De Gastroenterologia De Mexico|September 4, 2012
[The Best of the United European Gastroenterology Week (UEGW) 2011]B A Marfil-Garza, F J Bosques-Padilla
Revista De Gastroenterologia De Mexico (English)|December 15, 2020
Second Mexican consensus on biologic therapy and small-molecule inhibitors in inflammatory bowel diseaseJ K Yamamoto-Furusho, F J Bosques-Padilla, M A Martínez-Vázquez, et al.
Revista De Gastroenterologia De Mexico|April 29, 2010
[Considerations in evaluating the quality of life of patients with digestive, liver and bile disorders in Mexico]M A Martínez-Vázquez, M C Rodríguez-Leal, F J Bosques-Padilla
Revista De Gastroenterologia De Mexico|August 12, 2009
[Current concepts about the treatment of inflammatory bowel disease, biological therapy]F J Bosques-Padilla, S L Galindo-Marines, J K Yamamoto-Farusho
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 7, 2004
Characterisation of Helicobacter pylori isolates from the north-eastern region of MexicoE Garza-Gonzalez, F J Bosques-Padilla, R Tijerina-Menchaca, et al.
Journal of Chemotherapy (Florence, Italy)|February 11, 2005
Bacteriostatic and bactericidal activity of rabeprazole against Helicobacter pyloriE Garza-González, R Tijerina-Menchaca, G I Pérez-Pérez, et al.
Revista De Gastroenterologia De Mexico (English)|June 1, 2022
Caudate lobe hepatocellular carcinoma in a noncirrhotic patient with a history of chronic phenytoin intake and celiac disease treated with isolated caudate lobe resection. A case reportA Riojas-Garza, M González-Urquijo, C E Escareño-Pérez, et al.
International Journal of Immunogenetics|June 4, 2010
Genetic risk factors for inflammatory bowel disease in a North-eastern Mexican populationE Garza-González, G I Pérez-Pérez, S I Mendoza-Ibarra, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Revista De Gastroenterologia De Mexico (English)|May 14, 2019
Response to Dr. Isaac Ruiz from Dr. Francisco Javier Bosques Padilla, on behalf of the consensus group of the Mexican Consensus on the Treatment of Hepatitis CF J Bosques-Padilla
Revista De Gastroenterologia De Mexico|July 1, 1991
[Medical treatment of biliary lithiasis. Orally administered biliary acids]F J Bosques Padilla, R F Barragán Villarreal
Revista De Gastroenterologia De Mexico|September 4, 2012
[The Best of the United European Gastroenterology Week (UEGW) 2011]B A Marfil-Garza, F J Bosques-Padilla
Revista De Gastroenterologia De Mexico (English)|December 15, 2020
Second Mexican consensus on biologic therapy and small-molecule inhibitors in inflammatory bowel diseaseJ K Yamamoto-Furusho, F J Bosques-Padilla, M A Martínez-Vázquez, et al.
Revista De Gastroenterologia De Mexico|April 29, 2010
[Considerations in evaluating the quality of life of patients with digestive, liver and bile disorders in Mexico]M A Martínez-Vázquez, M C Rodríguez-Leal, F J Bosques-Padilla
Revista De Gastroenterologia De Mexico|August 12, 2009
[Current concepts about the treatment of inflammatory bowel disease, biological therapy]F J Bosques-Padilla, S L Galindo-Marines, J K Yamamoto-Farusho
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 7, 2004
Characterisation of Helicobacter pylori isolates from the north-eastern region of MexicoE Garza-Gonzalez, F J Bosques-Padilla, R Tijerina-Menchaca, et al.
Journal of Chemotherapy (Florence, Italy)|February 11, 2005
Bacteriostatic and bactericidal activity of rabeprazole against Helicobacter pyloriE Garza-González, R Tijerina-Menchaca, G I Pérez-Pérez, et al.
Revista De Gastroenterologia De Mexico (English)|June 1, 2022
Caudate lobe hepatocellular carcinoma in a noncirrhotic patient with a history of chronic phenytoin intake and celiac disease treated with isolated caudate lobe resection. A case reportA Riojas-Garza, M González-Urquijo, C E Escareño-Pérez, et al.
International Journal of Immunogenetics|June 4, 2010
Genetic risk factors for inflammatory bowel disease in a North-eastern Mexican populationE Garza-González, G I Pérez-Pérez, S I Mendoza-Ibarra, et al.
Pageof 3